AAVXF
Price:
$101.25
Market Cap:
$6.76B
Abivax S.A., a French biopharmaceutical firm, specializes in the discovery and enhancement of pharmaceutical treatments targeting inflammatory conditions, infectious illnesses, and various forms of cancer. The company's flagship compound, ABX464, is currently undergoing Phase IIb clinical evaluations for ulcerative colitis, Crohn's disease, and COVID-19. It is also being assessed in Phase IIa trials for rheumatoid arthritis, and has successfully concluded Phase IIa studies demonstrating viral remission in individuals with HIV. Additionally, Abivax is advancing ABX 196, an investigational immune-enhancing agent, through Phase 1/2 clinical trials for its potential application in treating hepat...[Read more]
Industry
Biotechnology
IPO Date
2016-09-27
Stock Exchange
OTC
Ticker
AAVXF
According to Abivax S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.29B. This represents a change of 166.64% compared to the average of 2.36B of the last 4 quarters.
The mean historical Enterprise Value of Abivax S.A. over the last ten years is 1.01B. The current 6.29B Enterprise Value has changed 62.18% with respect to the historical average. Over the past ten years (40 quarters), AAVXF's Enterprise Value was at its highest in in the December 2025 quarter at 7.90B. The Enterprise Value was at its lowest in in the December 2013 quarter at -442498.00.
Average
1.01B
Median
256.05M
Minimum
53.19M
Maximum
7.89B
Discovering the peaks and valleys of Abivax S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.98%
Maximum Annual Enterprise Value = 7.89B
Minimum Annual Increase = -70.00%
Minimum Annual Enterprise Value = 53.19M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 7.89B | 1.98% |
| 2024 | 379.33M | 67.53% |
| 2023 | 226.43M | 73.90% |
| 2022 | 130.21M | -70.00% |
| 2021 | 434.02M | -12.65% |
| 2020 | 496.85M | 73.93% |
| 2019 | 285.66M | 131.53% |
| 2018 | 123.38M | 48.12% |
| 2017 | 83.30M | 56.61% |
| 2016 | 53.19M | -61.15% |
The current Enterprise Value of Abivax S.A. (AAVXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.83B
5-year avg
1.81B
10-year avg
1.01B
Abivax S.A.’s Enterprise Value is less than Axsome Therapeutics, Inc. (12.89B), less than Merus N.V. (6.52B), less than Rhythm Pharmaceuticals, Inc. (6.56B), less than Nuvalent, Inc. (8.92B), greater than CRISPR Therapeutics AG (5.54B), less than Arcellx, Inc. (6.75B), less than Cytokinetics, Incorporated (10.73B), less than Jazz Pharmaceuticals plc (17.80B), less than Metsera, Inc. (6.98B), less than Arrowhead Pharmaceuticals, Inc. (12.39B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 12.89B | $12.97B | |
| 6.52B | $6.83B | |
| 6.56B | $6.40B | |
| 8.92B | $9.08B | |
| 5.54B | $5.17B | |
| 6.75B | $6.73B | |
| 10.73B | $9.58B | |
| 17.80B | $14.23B | |
| 6.98B | $7.43B | |
| 12.39B | $11.20B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abivax S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abivax S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Abivax S.A.'s Enterprise Value?
What is the highest Enterprise Value for Abivax S.A. (AAVXF)?
What is the 3-year average Enterprise Value for Abivax S.A. (AAVXF)?
What is the 5-year average Enterprise Value for Abivax S.A. (AAVXF)?
How does the current Enterprise Value for Abivax S.A. (AAVXF) compare to its historical average?